The decision follows the initial approval granted in September 2023, which covered patients aged five years and above.

For patients with severe elevations in low-density lipoprotein (LDL) cholesterol (≥190 mg/dL) and a combination of clinical signs and family history to suggest familial hypercholesterolemia (FH ...

Heart disease is often seen as a problem that only affects older adults, but more and more young people are being diagnosed ...

Do you have high cholesterol? You're not alone — millions of adults in the United States face this common but serious issue. High cholesterol increases the risk of heart disease, ...

In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines.

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...

Studies suggest that artichoke extract can help lower cholesterol and blood pressure, reduce liver inflammation, and aid with ...

The firm is hoping to show that the RNAi drug can treat HoFH by reducing production of ANGPTL3, which regulates lipid and lipoprotein metabolism.